Status not kept up to date
Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy
NCT06062706 · King Faisal Specialist Hospital & Research Center · Updated 2 Oct 2023
- What is being tested
- Donor hepatectomy
- For
- End Stage Liver Disease; Acute Liver Failure; Acute-On-Chronic Liver Failure; Hepatocellular Carcinoma
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 1 Month to 75 years. About 3,448 people. The full rules are on the registry page.
- Where
- Saudi Arabia
- When
- Starts or started 6 Aug 2023, ends 30 Oct 2023. Registered 2 Oct 2023.
- Results
- None posted yet.
In the researchers' words
This will be a study to examine the outcomes of open, laparoscopic, and robotic Living Donor Liver Transplantation (LDLT) procedures. The analysis will encompass 3,448 cases (1,724 donor-recipient pairs) from January 2011 to March 2023, documenting the transition between these surgical techniques, with a noted crossover in 2018.
Sites
- Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research CentreRiyadh, Saudi Arabia
